Ohio-based Navidea Biopharmaceuticals allies with a Chinese drug group to pursue regulatory approval and prepare distribution in the emerging market.
Navidea Biopharmaceuticals (NYSE:NAVB) is preparing major moves in China with a new alliance that aims to bring its Lymphoseek imaging agent to the country.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qgLQsw
Cap comentari:
Publica un comentari a l'entrada